The balance sheet strengthened dramatically with a $1.4B equity raise, lifting cash to $2.1B and cutting debt to $132M, resulting in a D/E ratio of just 0.04, though retained earnings remain -$1.1B.
| Total Current Assets | 2.9B | 1.37B | 692.62M | 476.72M | 662.29M | 774.76M | 93.11M | 124.63M |
| Cash & Short-Term Investments | 2.3B | 1.02B | 418.99M | 244.77M | 471.79M | 690.96M | 52.79M | 95.88M |
| Cash Only | 2.13B | 828.66M | 271.04M | 162.52M | 242.51M | 690.96M | 52.79M | 95.88M |
| Short-Term Investments | 172.7M | 187.92M | 147.95M | 82.25M | 229.28M | 0 | 0 | 0 |
| Accounts Receivable | 235.89M | 122.99M | 111.53M | 61.8M | 47.47M | 19.01M | 10.64M | 8.25M |
| Days Sales Outstanding | 77.67 | 74.59 | 93.32 | 92.22 | 82.11 | 111.49 | 110.51 | 62.21 |
| Inventory | 266.93M | 158.41M | 119.07M | 107.86M | 92.28M | 47.9M | 26.14M | 14.16M |
| Days Inventory Outstanding | 142.49 | 146.52 | 135.79 | 203.78 | 175.42 | 272.65 | 203.06 | 104.44 |
| Other Current Assets | 20.18M | 9.84M | 4.99M | 14.26M | 7.63M | 2.1M | 914K | 6.35M |
| Total Non-Current Assets | 1.29B | 958.93M | 491.72M | 464.49M | 326.83M | 206.08M | 94.75M | 70.56M |
| Property, Plant & Equipment | 519.99M | 423.74M | 262.9M | 219.8M | 152.37M | 93.76M | 76.73M | 65.72M |
| Fixed Asset Turnover | 1.73x | 1.42x | 1.66x | 1.11x | 1.38x | 0.66x | 0.46x | 0.74x |
| Goodwill | 299.07M | 205.75M | 71.02M | 71.02M | 71.02M | 43.31M | 3.13M | 0 |
| Intangible Assets | 320.42M | 224.75M | 58.64M | 68.09M | 79.69M | 57.49M | 11.35M | 1.33M |
| Long-Term Investments | 338.91M | 82.25M | 60.69M | 79.25M | 9.19M | 0 | 0 | 0 |
| Other Non-Current Assets | 34.12M | 20.56M | 35.47M | 22.83M | 10.66M | 5.67M | 1.14M | 3.5M |
| Total Assets | 4.19B | 2.32B | 1.18B | 941.21M | 989.12M | 980.85M | 187.87M | 195.19M |
| Asset Turnover | 0.27x | 0.26x | 0.37x | 0.26x | 0.21x | 0.06x | 0.19x | 0.25x |
| Asset Growth % | 483.22% | 96.27% | 25.83% | -4.84% | 0.84% | 422.09% | -3.75% | - |
| Total Current Liabilities | 528.2M | 334.48M | 339.52M | 223.37M | 162.94M | 96.31M | 48.42M | 31.94M |
| Accounts Payable | 0 | 72.7M | 53.06M | 29.3M | 12.08M | 3.49M | 3.37M | 6.46M |
| Days Payables Outstanding | 37.26 | 67.24 | 60.51 | 55.37 | 22.97 | 19.86 | 26.17 | 47.66 |
| Short-Term Debt | 0 | 0 | 12.04M | 17.76M | 2.91M | 2.83M | 0 | 0 |
| Deferred Revenue (Current) | 645.09M | 195.44M | 216.16M | 139.34M | 108.34M | 59.75M | 26.13M | 0 |
| Other Current Liabilities | 528.2M | 21.24M | 17.95M | 15.04M | 22.25M | 11M | 7.77M | 25.48M |
| Current Ratio | 5.48x | 4.08x | 2.04x | 2.13x | 4.06x | 8.04x | 1.92x | 3.90x |
| Quick Ratio | 4.98x | 3.61x | 1.69x | 1.65x | 3.50x | 7.55x | 1.38x | 3.46x |
| Cash Conversion Cycle | 182.9 | 153.87 | 168.61 | 240.64 | 234.56 | 364.28 | 287.4 | 118.99 |
| Total Non-Current Liabilities | 167.02M | 268.15M | 462.36M | 163.29M | 152.98M | 186.09M | 306.16M | 26.03M |
| Long-Term Debt | 14.85M | 154.11M | 389.44M | 87.59M | 100.04M | 97.3M | 0 | 26.02M |
| Capital Lease Obligations | 420.02M | 99.84M | 66.94M | 71.34M | 49.83M | 28.3M | 27.3M | 0 |
| Deferred Tax Liabilities | 15.75M | 1.24M | 891K | 426K | 95K | 466K | 0 | 0 |
| Other Non-Current Liabilities | 23.19M | 12.95M | 5.1M | 3.94M | 3M | 60.03M | 278.86M | 1K |
| Total Liabilities | 695.22M | 602.62M | 801.89M | 386.67M | 315.92M | 282.4M | 354.58M | 57.97M |
| Total Debt | 133.69M | 253.96M | 468.42M | 176.69M | 152.78M | 128.43M | 27.3M | 26.02M |
| Net Debt | -2B | -574.71M | 197.38M | 14.17M | -89.73M | -562.53M | -25.49M | -69.85M |
| Debt / Equity | 0.04x | 0.15x | 1.22x | 0.32x | 0.23x | 0.18x | - | 0.19x |
| Debt / EBITDA | -0.83x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 12.38x | - | - | - | - | - | - | - |
| Interest Coverage | -24.71x | -7.53x | -46.90x | -41.12x | -16.05x | -19.37x | - | - |
| Total Equity | 3.49B | 1.72B | 382.45M | 554.54M | 673.21M | 698.45M | -166.71M | 137.22M |
| Equity Growth % | 1387.57% | 350.21% | -31.03% | -17.63% | -3.61% | 518.96% | -221.49% | - |
| Book Value per Share | 5.55 | 3.24 | 0.77 | 1.15 | 1.44 | 1.54 | -0.37 | 0.34 |
| Total Shareholders' Equity | 3.49B | 1.72B | 382.45M | 554.54M | 673.21M | 698.45M | -166.71M | 137.22M |
| Common Stock | 60K | 54K | 50K | 49K | 48K | 45K | 8K | 0 |
| Retained Earnings | -1.11B | -1.01B | -813.7M | -623.53M | -440.95M | -305.01M | -187.69M | -132.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -8.57M | -1.96M | -2.81M | 1.54M | 1.14M | 1.31M | 1.05M | -79K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Neutron capex and cash burn
Total assets surged from $1.2B to $4.2B in 2026Q2, driven by a $1.4B equity raise, while debt fell to $132M, per the latest balance sheet data.
The balance sheet has transformed from a leveraged position with D/E of 1.22 in 2024Q4 to a fortress-like 0.04 in 2026Q2, primarily due to a massive equity infusion. This suggests management is prioritizing financial flexibility to fund Neutron development and potential acquisitions. However, the persistent negative retained earnings of -$1.1B indicate that the equity base is still supported by external capital rather than organic profitability.
Total debt dropped from $516.6M in 2025Q3 to $132.0M in 2026Q2, with D/E falling from 0.40 to 0.04, as reported in the balance sheet.
The dramatic deleveraging appears to be a strategic move to reduce refinancing risk and interest expense, especially as the company continues to burn cash. With debt now minimal, the balance sheet is well-positioned to weather development delays, but the prior debt levels suggest that the company may have used debt to bridge funding gaps. Investors should monitor whether this low leverage is maintained as Neutron capex intensifies.
Goodwill jumped from $71.0M to $299.1M in 2026Q2, while PPE grew to $520.0M, reflecting acquisition-driven growth and Neutron infrastructure, per the balance sheet.
The increase in goodwill and intangibles indicates that the company is pursuing a buy-versus-build strategy, particularly in Space Systems. This raises the risk of future impairment if acquired businesses underperform. PPE growth suggests significant investment in launch and manufacturing facilities, which is consistent with the capital-intensive nature of the Neutron program. The asset mix is shifting toward a more asset-heavy model, which may pressure returns in the near term.
Equity surged from $382.5M in 2024Q4 to $3.5B in 2026Q2, but retained earnings remain deeply negative at -$1.1B, as per the balance sheet.
The massive equity increase is primarily from a capital raise, not organic earnings, which dilutes existing shareholders. While this provides a substantial runway, the persistent negative retained earnings highlight that the company has not yet achieved profitability. The reliance on external equity suggests that future dilution may be necessary if cash burn continues, especially given the heavy SBC noted in the cash flow analysis.
Cash jumped to $2.1B in 2026Q2, with a current ratio of 5.48, up from 2.04 a year earlier, according to the balance sheet.
The liquidity position is now exceptionally strong, providing ample runway for ongoing operating losses and Neutron development. The current ratio of 5.48 indicates a robust ability to cover short-term obligations, which is crucial given the negative operating cash flow. However, the cash balance is likely to be consumed by the accelerating FCF burn, so investors should monitor the burn rate relative to this buffer.
Deferred revenue fell from $241.4M in 2026Q1 to $0 in 2026Q2, a sharp decline that may indicate a change in revenue recognition or contract terms, per the balance sheet.
The sudden drop in deferred revenue is non-obvious and warrants investigation. It could suggest that the company is recognizing revenue faster, possibly due to milestone completions, or that contracts are being restructured. This may inflate reported revenue in the short term but could reduce future visibility. Investors should scrutinize the backlog and contract asset trends to assess whether this is a one-time adjustment or a sustainable shift.
Quick answers to the most common questions about buying RKLB stock.
As of 2025, Rocket Lab USA, Inc. (RKLB) had total assets of $2.32B including $1.37B in current assets.
Rocket Lab USA, Inc. (RKLB) carries total debt of $254.0M, offset by $1.02B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Rocket Lab USA, Inc. (RKLB) has total shareholders' equity (book value) of $1.72B ($3.24 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Rocket Lab USA, Inc. (RKLB) reported a current ratio of 4.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.